Tempus AI , Inc. (NASDAQ:TEM) Chief Operating Officer Ryan Fukushima recently sold a significant portion of his holdings in the company, according to a recent SEC filing.The timing is notable as ...
Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.
Ryan Fukushima, the Chief Operating Officer of Tempus AI, Inc. (NASDAQ:TEM), recently sold a significant portion of his holdings in the company. According to a filing with the... ByInvesting.com ...